iSpecimen Inc. (ISPC)
- Previous Close
4.3200 - Open
4.2700 - Bid 4.1300 x 100
- Ask 4.4200 x 100
- Day's Range
4.1400 - 4.3850 - 52 Week Range
3.4100 - 14.6000 - Volume
57,729 - Avg. Volume
298,936 - Market Cap (intraday)
3.545M - Beta (5Y Monthly) 1.59
- PE Ratio (TTM)
-- - EPS (TTM)
-21.2000 - Earnings Date Aug 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
ispecimen.com53
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ISPC
View MorePerformance Overview: ISPC
Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISPC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISPC
View MoreValuation Measures
Market Cap
3.54M
Enterprise Value
1.42M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.20
Price/Book (mrq)
0.58
Enterprise Value/Revenue
0.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-97.04%
Return on Assets (ttm)
-43.46%
Return on Equity (ttm)
-98.03%
Revenue (ttm)
10.51M
Net Income Avi to Common (ttm)
-10.2M
Diluted EPS (ttm)
-21.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.15M
Total Debt/Equity (mrq)
0.48%
Levered Free Cash Flow (ttm)
-3.61M
Research Analysis: ISPC
View MoreCompany Insights: ISPC
ISPC does not have Company Insights